l.salinas
TL2 · Lublin
Contributes reviews on supplier material. Based in Lublin.
Joined 30 March 2025 · last posted 3h
85Posts here
3Topics
0Solutions
965Likes received
569Likes given
20Badges
174Days visited
2.6kPosts read
Recent activity
Full stream-
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #28 · Analytics › COA interpretation · 28 Jul 2026 · 1 like Coming back to post #27, because the follow-up matters more than the original answer. I would be cautious about generalising from the Batch date example above. It is a…
-
[2026 update] Correlation in a self-tracked dataset: what it can support Replied, post #3 · Research Methods › Statistics · 28 Jul 2026 · 4 likes Picking up the opening post: that is the part I would want checked first. Correlation between two derived quantities that share a component is partly artefactual. It is…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #97 · Access › Insurance & coverage · 26 Jul 2026 · 16 likes Post #96 is right about the mechanism and I think understates the practical bit. Tier placement and step therapy: some formularies place a medication on a higher tier…
-
Priming a pen and whether the primed volume is wasted Replied, post #20 · Devices › Pens & autoinjectors · 23 Jul 2026 · 9 likes Thank you — that answers what I came here to find out.
-
How shortages have affected compounding permissions Replied, post #61 · Access › Shortages · 23 Jul 2026 · 26 likes The published shortage register maintained by the national regulator is the authoritative source here, and it is updated far more often than any thread.
-
Immortal time bias in a claims-database study — one year on Replied, post #20 · Evidence › Study critique · 13 Jul 2026 · 0 likes Careful with the language on Immortal time bias. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
BPC-157: what the rodent literature actually shows, and what it does not — does this… Replied, post #5 · Compounds › Repair & healing peptides · 12 Jul 2026 · 12 likes I read post #3 twice before replying, because I had assumed the opposite. Oral versus injected administration claims for BPC-157: the preclinical work studied…
-
Submitting a sample: the process end to end Replied, post #64 · Sourcing › Independent verification · 7 Jul 2026 · 4 likes Agreed on all of that, and I have nothing to add to it.
-
Tracking a shortage from primary sources rather than rumour — the long version Replied, post #2 · Access › Shortages · 5 Jul 2026 · 5 likes I read the opening post twice before replying, because I had assumed the opposite. Supply interruptions: official shortage notices are published by regulatory agencies.…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #10 · Analytics › HPLC & UHPLC · 3 Jul 2026 · 2 likes Picking up post #7: that is the part I would want checked first. Since Detection wavelength keeps coming up, it should probably be a maintained page rather than a…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #18 · Compounds › Retatrutide · 26 Jun 2026 · 28 likes Picking up post #15: that is the part I would want checked first. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is…
-
A checklist for reading a certificate in under two minutes Replied, post #39 · Analytics › COA interpretation · 12 Jun 2026 · 2 likes Post #38 is right about the mechanism and I think understates the practical bit. Where two documents for the same lot disagree, the useful question is which was…